Francesco Del Galdo, MD, PhD

University of Leeds
Leeds, United Kingdom

Head of the Raynaud's and Scleroderma Programme in the Institute of Rheumatic and Musculoskeletal Medicine and NIHR Biomedical Research Centre in Leeds. Professor Del Galdo is an Italian MD graduate who completed his PhD in 2007 and served as associate Director of the scleroderma Center at Thomas Jefferson University until 2009. Prof Del Galdo main interests are in improving patient outcome through a biomarker led stratified approach to diagnostic and clinical interventions. Since 2022 Prof Del Galdo is the President of EUSTAR, the European Scleroderma And Research consortium.

Disclosure information not submitted.

Presentation(s):

• 0523: The Development of the Ranked Composite Important Difference in Diffuse Cutaneous Systemic Sclerosis; A Clinical and Patient Meaningful Anchor to the ACR-Composite Response Index in SSc

  Saturday, November 12, 2022
  4:15 PM – 4:25 PM Eastern Time

• 1065: Biosamples from VEDOSS Patients Show Pathological Signs of SSc: Opportunity for a Biololgical Diagnosis of Disease

  Sunday, November 13, 2022
  9:00 AM – 10:30 AM Eastern Time

• 570: CH Scleroderma: Difficult to Manage Raynaud's Phenomenon and Digital Ulcers

  Sunday, November 13, 2022
  1:00 PM – 1:45 PM Eastern Time

• 1065: Biosamples from VEDOSS Patients Show Pathological Signs of SSc: Opportunity for a Biological Diagnosis of Disease

  Sunday, November 13, 2022
  1:15 PM – 1:20 PM Eastern Time

• 2170: Validation of Ranked Composite Important Difference (RCID) Score in Early Diffuse Cutaneous Systemic Sclerosis

  Sunday, November 13, 2022
  1:45 PM – 1:50 PM Eastern Time

• 2170: Validation of Ranked Composite Important Difference (RCID) Score in Early Diffuse Cutaneous Systemic Sclerosis

  Monday, November 14, 2022
  1:00 PM – 3:00 PM Eastern Time